New drug aims to boost oxygen in blood transfusions
NCT ID NCT03999229
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether giving a drug that adds a small molecule to red blood cells can improve how much oxygen gets to tissues during a blood transfusion. Healthy volunteers will receive their own stored blood with or without the drug, and researchers will measure oxygen levels in blood and tissues. The goal is to see if this approach is safe and could help prevent complications from transfusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSFUSION RELATED COMPLICATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.